vs
伟创力（FLEX）与辉瑞（PFE）财务数据对比。点击上方公司名可切换其他公司
辉瑞的季度营收约是伟创力的1.9倍（$14.5B vs $7.5B），辉瑞净利率更高（18.6% vs 3.3%，领先15.3%），伟创力同比增速更快（16.9% vs 5.0%），过去两年伟创力的营收复合增速更高（8.8% vs 4.3%）
伟创力（Flex Ltd.）是一家拥有新加坡与美国背景的跨国制造企业，按营收计算为全球第三大电子制造服务（EMS）及原始设计制造商（ODM），仅次于和硕。其美国总部位于得克萨斯州奥斯汀，在30多个国家设有生产基地，员工总数约17.2万人。
辉瑞是总部位于美国纽约曼哈顿The Spiral的跨国制药及生物技术企业，由德国企业家查尔斯·辉瑞与查尔斯·F·埃尔哈特于1849年在纽约创立，是北美地区历史最悠久的制药企业之一，在全球医药健康领域拥有较高的行业影响力。
FLEX vs PFE — 直观对比
营收规模更大
PFE
是对方的1.9倍
$7.5B
营收增速更快
FLEX
高出11.9%
5.0%
净利率更高
PFE
高出15.3%
3.3%
两年增速更快
FLEX
近两年复合增速
4.3%
损益表 — Q4 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.5B | $14.5B |
| 净利润 | $250.0M | $2.7B |
| 毛利率 | 9.4% | — |
| 营业利润率 | 5.0% | — |
| 净利率 | 3.3% | 18.6% |
| 营收同比 | 16.9% | 5.0% |
| 净利润同比 | 12.6% | — |
| 每股收益（稀释后） | $0.67 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLEXPFE
| Q1 26 | $7.5B | $14.5B | ||
| Q4 25 | $7.1B | $17.6B | ||
| Q3 25 | $6.8B | $16.7B | ||
| Q2 25 | $6.6B | $14.7B | ||
| Q1 25 | $6.4B | $13.7B | ||
| Q4 24 | $6.6B | $17.8B | ||
| Q3 24 | $6.5B | $17.7B | ||
| Q2 24 | $6.3B | $13.3B |
净利润FLEXPFE
| Q1 26 | $250.0M | $2.7B | ||
| Q4 25 | $239.0M | $-1.6B | ||
| Q3 25 | $199.0M | $3.5B | ||
| Q2 25 | $192.0M | $2.9B | ||
| Q1 25 | $222.0M | $3.0B | ||
| Q4 24 | $263.0M | $410.0M | ||
| Q3 24 | $214.0M | $4.5B | ||
| Q2 24 | $139.0M | $41.0M |
毛利率FLEXPFE
| Q1 26 | 9.4% | — | ||
| Q4 25 | 9.6% | 70.0% | ||
| Q3 25 | 9.0% | 74.9% | ||
| Q2 25 | 8.7% | 74.2% | ||
| Q1 25 | 8.8% | 79.3% | ||
| Q4 24 | 9.1% | 66.7% | ||
| Q3 24 | 8.1% | 70.3% | ||
| Q2 24 | 7.5% | 75.2% |
营业利润率FLEXPFE
| Q1 26 | 5.0% | — | ||
| Q4 25 | 5.5% | -9.4% | ||
| Q3 25 | 4.4% | 20.0% | ||
| Q2 25 | 4.7% | 20.8% | ||
| Q1 25 | 4.8% | 20.3% | ||
| Q4 24 | 5.1% | -0.1% | ||
| Q3 24 | 4.5% | 26.6% | ||
| Q2 24 | 3.7% | -0.8% |
净利率FLEXPFE
| Q1 26 | 3.3% | 18.6% | ||
| Q4 25 | 3.4% | -9.4% | ||
| Q3 25 | 2.9% | 21.3% | ||
| Q2 25 | 2.9% | 19.9% | ||
| Q1 25 | 3.5% | 21.6% | ||
| Q4 24 | 4.0% | 2.3% | ||
| Q3 24 | 3.3% | 25.2% | ||
| Q2 24 | 2.2% | 0.3% |
每股收益（稀释后）FLEXPFE
| Q1 26 | $0.67 | $0.47 | ||
| Q4 25 | $0.64 | $-0.29 | ||
| Q3 25 | $0.52 | $0.62 | ||
| Q2 25 | $0.50 | $0.51 | ||
| Q1 25 | $0.56 | $0.52 | ||
| Q4 24 | $0.67 | $0.07 | ||
| Q3 24 | $0.54 | $0.78 | ||
| Q2 24 | $0.34 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | — |
| 总债务越低越好 | $3.8B | — |
| 股东权益账面价值 | $5.1B | — |
| 总资产 | $22.1B | — |
| 负债/权益比越低杠杆越低 | 0.73× | — |
8季度趋势，按日历期对齐
现金及短期投资FLEXPFE
| Q1 26 | $2.4B | — | ||
| Q4 25 | $3.1B | $1.1B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.2B | $1.6B | ||
| Q1 25 | $2.3B | $1.4B | ||
| Q4 24 | $2.3B | $1.0B | ||
| Q3 24 | $2.6B | $1.1B | ||
| Q2 24 | $2.2B | $1.1B |
总债务FLEXPFE
| Q1 26 | $3.8B | — | ||
| Q4 25 | $4.4B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $3.7B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.2B | — |
股东权益FLEXPFE
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.1B | $86.5B | ||
| Q3 25 | $5.0B | $92.8B | ||
| Q2 25 | $5.1B | $88.7B | ||
| Q1 25 | $5.0B | $90.3B | ||
| Q4 24 | $5.0B | $88.2B | ||
| Q3 24 | $5.0B | $92.3B | ||
| Q2 24 | $5.0B | $87.7B |
总资产FLEXPFE
| Q1 26 | $22.1B | — | ||
| Q4 25 | $20.8B | $208.2B | ||
| Q3 25 | $19.5B | $208.7B | ||
| Q2 25 | $19.1B | $206.1B | ||
| Q1 25 | $18.4B | $208.0B | ||
| Q4 24 | $18.3B | $213.4B | ||
| Q3 24 | $18.6B | $219.5B | ||
| Q2 24 | $17.7B | $216.2B |
负债/权益比FLEXPFE
| Q1 26 | 0.73× | — | ||
| Q4 25 | 0.87× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.64× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $413.0M | — |
| 自由现金流经营现金流 - 资本支出 | $212.0M | — |
| 自由现金流率自由现金流/营收 | 2.8% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | — |
8季度趋势，按日历期对齐
经营现金流FLEXPFE
| Q1 26 | $413.0M | — | ||
| Q4 25 | $420.0M | $5.3B | ||
| Q3 25 | $453.0M | $4.6B | ||
| Q2 25 | $399.0M | $-582.0M | ||
| Q1 25 | $433.0M | $2.3B | ||
| Q4 24 | $413.0M | $6.7B | ||
| Q3 24 | $319.0M | $6.7B | ||
| Q2 24 | $340.0M | $-1.8B |
自由现金流FLEXPFE
| Q1 26 | $212.0M | — | ||
| Q4 25 | $272.0M | $4.5B | ||
| Q3 25 | $303.0M | $4.0B | ||
| Q2 25 | $266.0M | $-1.2B | ||
| Q1 25 | $321.0M | $1.8B | ||
| Q4 24 | $301.0M | $5.8B | ||
| Q3 24 | $216.0M | $6.1B | ||
| Q2 24 | $229.0M | $-2.4B |
自由现金流率FLEXPFE
| Q1 26 | 2.8% | — | ||
| Q4 25 | 3.9% | 25.6% | ||
| Q3 25 | 4.5% | 24.0% | ||
| Q2 25 | 4.0% | -8.2% | ||
| Q1 25 | 5.0% | 12.9% | ||
| Q4 24 | 4.6% | 32.7% | ||
| Q3 24 | 3.3% | 34.3% | ||
| Q2 24 | 3.6% | -18.2% |
资本支出强度FLEXPFE
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 4.8% | ||
| Q3 25 | 2.2% | 3.6% | ||
| Q2 25 | 2.0% | 4.2% | ||
| Q1 25 | 1.8% | 4.1% | ||
| Q4 24 | 1.7% | 5.2% | ||
| Q3 24 | 1.6% | 3.7% | ||
| Q2 24 | 1.8% | 4.8% |
现金转化率FLEXPFE
| Q1 26 | 1.65× | — | ||
| Q4 25 | 1.76× | — | ||
| Q3 25 | 2.28× | 1.30× | ||
| Q2 25 | 2.08× | -0.20× | ||
| Q1 25 | 1.95× | 0.79× | ||
| Q4 24 | 1.57× | 16.39× | ||
| Q3 24 | 1.49× | 1.50× | ||
| Q2 24 | 2.45× | -43.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLEX
暂无分部数据
PFE
| Product revenues | $11.7B | 81% |
| Alliance revenues | $2.3B | 16% |
| Royalty revenues | $396.0M | 3% |
